Award
Delivery Order #75F40126F19009
Three-Year Task Order for Medical Writing Support to FDA CBER
Buyer
Food and Drug Administration
Award Amount
$2,855,873.60
Ceiling
$8,828,529.66
Awarded
September 28, 2026
Period of Performance
Sep 28, 2026 – Sep 27, 2027
Identifier
75F40126F19009
NAICS
541990
This award represents a definitive three-year labor-hour task order granted to Kaiva Strategies, LLC, a specialized firm in medical writing and scientific communication. The contract supports the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research, specifically its Office of Biostatistics and Pharmacovigilance, by providing expert medical writing services focused on post-market surveillance. This contract is significant as it enhances the FDA's ability to analyze and communicate critical safety data for biologics, ultimately contributing to public health protection. The scope of work includes delivering detailed scientific documents and reports that inform regulatory decision-making and safety monitoring. This task order continues under a comprehensive indefinite delivery/indefinite quantity contract initially awarded competitively to Kaiva Strategies, demonstrating the agency's confidence in the company's capabilities. The performance period spans a recent multi-year timeframe with potential extension, ensuring sustained support to FDA initiatives. The contract is performed in Silver Spring, Maryland, where the FDA is headquartered, facilitating close collaboration. No subcontractors were identified for this award, and it builds upon Kaiva Strategies' proven record of delivering health communication services to federal health agencies.
Description
3-YEAR, LABOR-HOUR (LH) TYPE TASK ORDER FOR MEDICAL WRITERS SUPPORT SERVICES (POST-MARKET SURVEILLANCE) TO SUPPORT THE U.S. FOOD AND DRUG ADMINISTRATION (FDA), CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER), OFFICE OF BIOSTATISTICS AND PHARMACOV